Eintrag weiter verarbeiten
Verfügbar über Online-Ressource

Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: OncoTargets and Therapy
Personen und Körperschaften: Cui J, Wang J, Lin C, Liu J, Zuo W
In: OncoTargets and Therapy, 2019, S. 10177-10185
Format: E-Article
Sprache: Englisch
author_facet Cui J
Wang J
Lin C
Liu J
Zuo W
Cui J
Wang J
Lin C
Liu J
Zuo W
author Cui J
Wang J
Lin C
Liu J
Zuo W
spellingShingle Cui J
Wang J
Lin C
Liu J
Zuo W
OncoTargets and Therapy
Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
author_sort cui j
spelling Cui J Wang J Lin C Liu J Zuo W 1178-6930 https://doaj.org/article/34b853268b804b3bac727ee125719a64 Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells OncoTargets and Therapy
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-28-34b853268b804b3bac727ee125719a64
id ai-28-34b853268b804b3bac727ee125719a64
institution DE-540
DE-D275
DE-D117
DE-Bn3
DE-Zwi2
DE-D161
DE-15
DE-14
imprint 2019
imprint_str_mv 2019
issn 1178-6930
issn_str_mv 1178-6930
language English
mega_collection DOAJ Directory of Open Access Journals
match_str j2019osteopontinmediatescetuximabresistanceviathemapkpathwayinnsclccells
publishDateSort 2019
record_id 34b853268b804b3bac727ee125719a64
recordtype ai
record_format ai
series OncoTargets and Therapy
source_id 28
title Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_unstemmed Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_full Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_fullStr Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_full_unstemmed Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_short Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_sort osteopontin mediates cetuximab resistance via the mapk pathway in nsclc cells
url https://doaj.org/article/34b853268b804b3bac727ee125719a64
publishDate 2019
physical 10177-10185
description
container_start_page 10177
container_title OncoTargets and Therapy
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792356382444355601
geogr_code not assigned
last_indexed 2024-03-01T20:17:27.267Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Osteopontin+Mediates+Cetuximab+Resistance+via+the+MAPK+Pathway+in+NSCLC+Cells&rft.date=2019-11-01&genre=article&rft_id=34b853268b804b3bac727ee125719a64&issn=1178-6930&spage=10177&epage=10185&pages=10177-10185&jtitle=OncoTargets+and+Therapy&atitle=Osteopontin+Mediates+Cetuximab+Resistance+via+the+MAPK+Pathway+in+NSCLC+Cells&au=Zuo+W&rft.language%5B0%5D=eng
SOLR
_version_ 1792356382444355601
author Cui J, Wang J, Lin C, Liu J, Zuo W
author_facet Cui J, Wang J, Lin C, Liu J, Zuo W, Cui J, Wang J, Lin C, Liu J, Zuo W
author_sort cui j
container_start_page 10177
container_title OncoTargets and Therapy
description
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-28-34b853268b804b3bac727ee125719a64
imprint 2019
imprint_str_mv 2019
institution DE-540, DE-D275, DE-D117, DE-Bn3, DE-Zwi2, DE-D161, DE-15, DE-14
issn 1178-6930
issn_str_mv 1178-6930
language English
last_indexed 2024-03-01T20:17:27.267Z
match_str j2019osteopontinmediatescetuximabresistanceviathemapkpathwayinnsclccells
mega_collection DOAJ Directory of Open Access Journals
physical 10177-10185
publishDate 2019
publishDateSort 2019
record_format ai
record_id 34b853268b804b3bac727ee125719a64
recordtype ai
series OncoTargets and Therapy
source_id 28
spelling Cui J Wang J Lin C Liu J Zuo W 1178-6930 https://doaj.org/article/34b853268b804b3bac727ee125719a64 Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells OncoTargets and Therapy
spellingShingle Cui J, Wang J, Lin C, Liu J, Zuo W, OncoTargets and Therapy, Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_full Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_fullStr Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_full_unstemmed Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_short Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
title_sort osteopontin mediates cetuximab resistance via the mapk pathway in nsclc cells
title_unstemmed Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
url https://doaj.org/article/34b853268b804b3bac727ee125719a64